Refine by
Gene Expressions Suppliers & Manufacturers
11 companies found
Technologybased inSouth San Francisco, CALIFORNIA (USA)
Superfluid’s platform technology is applicable to a wide variety of diseases. We are currently focused on Alzheimer’s Disease, where there are urgent medical needs. This minimally invasive approach eliminates the need for spinal taps and ...
Key developments in molecular biology, bioinformatics and drug development have positioned Molecular Stethoscope to leverage cf-mRNA to create accurate and clinically useful diagnostic ...
Technologybased inDelhi, INDIA
Premas Life Sciences (PLS) is a young, dynamic, and focused organization introducing game-changing niche technologies in Genomics, Cell Biology, and Biopharma to boost innovative research and diagnostics in India. We are also the knowledge partners ...
Make next-generation sequencing easier and more affordable than ever. The smallest, most affordable Illumina sequencing system delivers fast and efficient lowthroughput sequencing for virtually any lab. ...
Technologybased inHamburg, GERMANY
Revvity Gene Delivery (formerly SIRION Biotech) supports your cell and gene therapy development process ̶ offering solutions for early R&D all the way to clinical applications, with easy transfer of processes and assays into GMP production. ...
Adenoviral vectors offer high levels of transgene expression in broad cell types, including dividing and non-dividing cells. Adenoviral vectors are the method of choice whenever fast and transient gene ...
Technologybased inTaipei, City, TAIWAN
Bened Biomedical Co., Ltd. was founded in 2015 in Taipei, Taiwan. One of its founders, Professor Ying-Chieh Tsai (National Yang-Ming University), has spent decades studying fermentation and probiotics. It was in his lab where Bened’s first ...
Isolated from the human gut, Safe (GRAS pending, L. paracasei species EFSA QPS), Vegan, kosher and halal, Clinically studied for safety and effectiveness, VigorBiotics (PS23 strain postbiotics): shelf-stable, no need for refrigeration, resistant to ...
Technologybased inDaejeon, SOUTH KOREA
We are exploring sequence-based drug discovery and development, which is bypassing the need for 3D structure. ...
WX presents biomarkers, based on raw transcriptome data. It is an artificial intelligence technology that can predict biomarkers, prognostic biomarkers and even the mode of action (MOA) of disease ...
Technologybased inDavis, CALIFORNIA (USA)
Headquartered in Davis, California, Expression Systems is dedicated to supplying and servicing the baculovirus, cell culture and bio-industrial markets with innovative media formulations, complementary products and contract services. We specialize ...
Expression Systems’ contract production services can assist you at any step of the process, solving technical problems in molecular biology, purification or other issues relating to BEVS. ...
Technologybased inNess Ziona, ISRAEL
Science in Action (SIA) is a boutique preclinical contract research organization (CRO) founded in 2010 by immunologist Raanan Margalit. SIA is GLP-accredited for toxicology studies in multiple areas. SIA has extensive experience in tailor-made ...
Technologybased inLund, SWEDEN
To understand and cure the diseases that still plague humanity, medical science needs new tools that gain widespread scientific use by being affordable to all scientists. Close to 20 years ago this, together with the excitement of working with ...
Technologybased inCarmel, INDIANA (USA)
Sword Diagnostics is a cutting-edge life sciences company created in response to the rapidly evolving needs of the research and pharmaceutical communities. Although researchers are discovering thousands of biomarkers associated with both healthy and ...
Technologybased inFriendswood, TEXAS (USA)
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and ...
Predicting Individual Risk of Recurrence or Metastasis: DecisionDx-Melanoma was designed to address the need for a more accurate predictor of metastatic risk in patients diagnosed with cutaneous (skin) melanoma. ...
Technologybased inParis, FRANCE
Biogemma is a European plant biotechnology company founded in 1997 by seed companies and French field crop producers. Its original mission was to create new genetic variability via GM traits to be exploited by its shareholding companies. With the ...
Biogemma is built around 4 core platforms in 4 species, and an upstream technology ...
